StonvexLoading…
StonvexStonvexStonvexCore line items from HVT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $189.05M | $759.00M | $557.08M | $362.59M |
Operating Income | $5.96M | $26.83M | $16.04M | $9.62M |
Net Income | $4.26M | $19.73M | $11.20M | $6.47M |
EPS (Diluted) | Not available | Not available | Not available | Not available |
Total Assets | $647.34M | $649.05M | $651.71M | $642.67M |
Total Liabilities | $340.73M | $341.12M | $345.68M | $337.80M |
Cash & Equivalents | $107.46M | $125.33M | $130.50M | $107.36M |
Free Cash Flow OCF − CapEx | $-9.86M | $32.97M | $30.01M | $1.68M |
Shares Outstanding | Not available | Not available | Not available | Not available |